U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07497854) titled 'A Study to Learn About the Study Medicine NURTEC(R) ODT 75 mg After it is Released Into the Markets in Korea' on Feb. 28.
Brief Summary: The purpose of this study is to evaluate safety and effectiveness of NURTEC(R) ODT 75 mg (Rimegepant sulfate) in adult patients with acute treatment of migraine with or without aura and with preventive treatment of episodic migraine during the PMS period as required by the Korean ministry of food and drug safety (MFDS).
Study Start Date: Oct. 01, 2026
Study Type: OBSERVATIONAL
Condition:
Migraine With or Without Aura
Intervention:
DRUG: Rimegepant sulfate
ALL Who treated with Rimegepant sul...